India Ornidazole Market to grow at brisk rate through FY2026
Growing prevalence of
infections is expected to drive the growth of India ornidazole market
According
to TechSci Research report, “India Ornidazole Market By Composition (Single,
Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By
Form (Tablet, Injection, Capsule, Others), By Route of Administration (Oral v/s
Intravenous), By Distribution Channel (Online v/s Offline), By Application
(Vaginal Infections, Urinary Tract Infections, Intestinal Infections,
Trichomoniasis, Others), By End User (Adult v/s Pediatric), By Company, By
Region, Forecast & Opportunities, FY2026”, the India ornidazole market is expected to grow at a steady
rate during the forecast period on account of the treatment of bacterial and
parasitic infections. The drug is used in the treatment of infections of liver,
stomach & intestine, vagina, among others. This in turn is expected to fuel
the market growth through FY2026. Additionally, ornidazole is used in the
treatment of dental infections thereby spurring the market growth over the next
few years. Also, the drug is helpful in treating leg ulcers and pressure soars.
However, side effects such as nausea, headache, vomiting, stomach pain, among
others associated with the intake of ornidazole can restrict the market growth
during the forecast period. Furthermore, other common side effects include
dryness in mouth, metallic taste, among others can further impede the market
growth over the next five years.
Browse XX market data Tables and XX
Figures spread through XXX
Pages and an in-depth TOC on" India Ornidazole Market "
https://www.techsciresearch.com/report/india-ornidazole-market/5170.html
The India ornidazole market is segmented based on composition, source, form,
route of administration, distribution channel, application, end user, company
and region. Based on form, the market can be categorized into tablet, capsule, injection
and others. The tablet segment is expected to dominate the market since it can
accommodate a large amount of API as compared to the other counterparts. While
capsule segment is expected to register the highest growth during the forecast
period on account of the associated benefits such as fast action, tamper
resistance, higher rate of absorption, among others. Based on route of
administration, the market can be bifurcated into oral and intravenous. The
oral route is expected to dominate the market owing to the benefits such as
absorption across the complete long of GI tract patient compliance, pain free
and easy administration, among others. While the intravenous route is expected
to witness significant growth owing to the fact that using this route of
administration a higher dose of the drug can be administered. Additionally,
this route has 100% bioavailability and also helps in achieving desired blood
concentration. Based on distribution channel, the market can be split into
online and offline. The offline channel is expected to dominate the market
owing to the consumer preference for buying medicines from a pharmacy or drug
store. The online segment is also expected to register significant growth over
the next few years. This can be ascribed to the emergence of several online
pharmacies and doorstep drug delivery e-commerce platforms in the country.
Intas Pharmaceuticals Ltd., Wellona Pharma Pvt. Ltd., Salvavidas
Pharmaceutical Pvt. Ltd., Actiza Pharmaceutical Pvt. Ltd., Facemed
Pharmaceuticals Pvt. Ltd., Taj Pharmaceuticals Ltd., Abbott Healthcare Pvt.
Ltd., Anuja Healthcare Ltd., Heer Pharma Pvt. Ltd., Intra Labs India Pvt. Ltd. and
others are some of the leading players operating in India ornidazole market. Companies operating in the market are using organic
strategies such as product launches, mergers and acquisitions, research collaborations
to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5170
Customers can also request for 10% free customization on
this report.
“India ornidazole market is expected to
witness growth during the forecast period on account of the growing incidences
of urinary tract infections, vaginal infections, among others. Furthermore,
supportive government policies and schemes launched by the government of India
such as incentive linked production scheme, establishment of bulk drug parks, China
plus one strategy, Vocal for Local, among others.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Ornidazole Market By Composition (Single,
Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By
Form (Tablet, Injection, Capsule, Others), By Route of Administration (Oral v/s
Intravenous), By Distribution Channel (Online v/s Offline), By Application
(Vaginal Infections, Urinary Tract Infections, Intestinal Infections,
Trichomoniasis, Others), By End User (Adult v/s Pediatric), By Company, By
Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India ornidazole
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India ornidazole market.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]